Combination of BMI1 and MAPK/ERK inhibitors is effective in medulloblastoma.
Combination of BMI1 and MAPK/ERK inhibitors is effective in medulloblastoma.
复制标题
DOI:
10.1093/neuonc/noac052
复制
发表时间:
2022-08-01
期刊:
影响因子:
15.9
通讯作者:
中科院分区:
文献类型:
--
作者:
Epigenetic changes play a key role in the pathogenesis of medulloblastoma (MB), the most common malignant pediatric brain tumor. We explore the therapeutic potential of BMI1 and MAPK/ERK inhibition in BMI1High;CHD7Low MB cells and in a preclinical xenograft model. We identify a synergistic vulnerability of BMI1High;CHD7Low MB cells to a combination treatment with BMI1 and MAPK/ERK inhibitors. Mechanistically, CHD7-dependent binding of BMI1 to MAPK-regulated genes underpins the CHD7-BMI1-MAPK regulatory axis responsible of the antitumour effect of the inhibitors in vitro and in a preclinical mouse model. Increased ERK1 and ERK2 phosphorylation activity is found in BMI1High;CHD7Low G4 MB patients, raising the possibility that they could be amenable to a similar therapy. The molecular dissection of the CHD7-BMI1-MAPK regulatory axis in BMI1High;CHD7Low MB identifies this signature as a proxy to predict MAPK functional activation, which can be effectively drugged in preclinical models, and paves the way for further exploration of combined BMI1 and MAPK targeting in G4 MB patients.
登录
查看更多内容
影响因子:
16.6
作者:
Badodi S;Pomella N;Zhang X;Rosser G;Whittingham J;Niklison-Chirou MV;Lim YM;Brandner S;Morrison G;Pollard SM;Bennett CD;Clifford SC;Peet A;Basson MA;Marino S
通讯作者:
Marino S
影响因子:
50.3
作者:
Gargiulo, Gaetano;Cesaroni, Matteo;van Lohuizen, Maarten
通讯作者:
van Lohuizen, Maarten
影响因子:
8.8
作者:
Badodi S;Dubuc A;Zhang X;Rosser G;Da Cunha Jaeger M;Kameda-Smith MM;Morrissy AS;Guilhamon P;Suetterlin P;Li XN;Guglielmi L;Merve A;Farooq H;Lupien M;Singh SK;Basson MA;Taylor MD;Marino S
通讯作者:
Marino S
影响因子:
9
作者:
Frisira, Eleni;Rashid, Fatima;Niklison-Chirou, Maria Victoria
通讯作者:
Niklison-Chirou, Maria Victoria
影响因子:
8
作者:
Bakhshinyan, David;Venugopal, Chitra;Singh, Sheila K.
通讯作者:
Singh, Sheila K.